Health
China’s Covid-19 vaccine candidate proves safe in initial tests – Hindustan Times
Scientists have said that despite the vaccine proving safe, no data to establish the final efficacy.
Researchers in China have confirmed that BBIBP-CorV, a vaccine currently under human trial observation, has safely triggered the expected antibody immune responses.
The combined early and mid-stage trials for the vaccine happened between April 29 and July 30 this year.
Beijing Institute of Biological Products, a subsidiary of China National Biotec Group (CNBG), is currently developing the vaccine. It is one of ten potential vaccine candidates that have entered the Phase III trials around the …
-
Noosa News23 hours agoTrump’s trade war puts Australian beef centre stage in Shanghai
-
General22 hours agoCoomalie council dismissed by NT government after investigation finds ‘serious deficiencies’
-
Noosa News22 hours agoHuge suburban crowd cheers for luxury house sale at sausage sizzle auction
-
General23 hours agoGrain growers face costly nightmare of ‘clumped’ fertiliser